Department of Military Affairs Tender by Indian Army (GEM/2025/B/6024223)
Human Papilloma Virus Quadrivalent (Type 6, 11, 16, 18) Vaccine Recombinant PFS of 0.5 ml
Tender Timeline
Tender Title: Human Papilloma Virus Quadrivalent Vaccine Procurement
Reference Number: GEM/2025/B/6024223
Issuing Authority/Department
The tender is issued by the Department of Military Affairs, under the Ministry of Defence. This department plays a pivotal role in ensuring the health and well-being of personnel by providing necessary medical supplies.
Scope of Work and Objectives
The primary objective of this tender is to procure Human Papilloma Virus Quadrivalent (Type 6, 11, 16, 18) Vaccine Recombinant PFS of 0.5 ml. The total quantity required for this procurement is 260 units. This vaccine has a critical role in preventing HPV-related diseases, and it is imperative to ensure that it meets the highest standards of efficacy and safety for usage within the military context.
Eligibility Criteria
To participate in this tender, bidders must:
- Be a registered entity with relevant government authorities.
- Have experience in supplying vaccines or similar medical products.
- Demonstrate compliance with national quality standards for vaccines.
Technical Requirements
The specifications for the vaccine include the following:
- The vaccine should be formulated as a recombinant product.
- Each unit must contain 0.5 ml of the Quadrivalent composition targeting types 6, 11, 16, and 18.
- Comprehensive documentation supporting the vaccine's production processes, quality assurance, and clinical trial data is mandatory.
Financial Requirements
Bidders must submit a complete financial proposal, which should include:
- A detailed quotation for the total cost of the vaccines.
- Any applicable taxes and delivery charges.
- Payment terms, which should be clear and concise.
Document Submission Details
All documents must be submitted in the prescribed format, including:
- Company registration certificates.
- Relevant experience proof.
- Technical bid and financial bid, submitted separately. Bidders must ensure that submission follows the guidelines specified in the tender announcement to avoid disqualification.
Special Provisions
This tender may include special provisions for Micro, Small, and Medium Enterprises (MSEs) and could potentially provide startup benefits to encourage participation from smaller companies, fostering innovation and competition.
Evaluation Process
The evaluation of bids will be conducted based on:
- Compliance with eligibility criteria.
- Technical specifications adherence.
- Financial competitiveness. The best bid will not solely focus on the lowest price but also consider the quality and reliability of the products offered.
Delivery Locations
Vaccines will need to be delivered to military health facilities as determined by the Department of Military Affairs upon successful awarding of the contract. Bidders should specify their capability for logistics and delivery timelines.
Contact Information
For further inquiries related to the tender, please reach out to the Department of Military Affairs through official communication channels. Additional details or contact information are not specified to ensure confidentiality and security.
In conclusion, this tender presents a significant opportunity for qualified suppliers to contribute to the health and safety of military personnel through the procurement of a vital vaccine. Participation requires adherence to stringent quality and financial guidelines to ensure only the best products are delivered.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
4 DocumentsDocuments Required from Seller
- Experience Criteria
- Past Performance
- Bidder Turnover
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- OEM Annual Turnover *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity, having relevant experience in supplying vaccines or similar medical products, and demonstrating compliance with national quality standards for vaccines. Bidders must provide necessary documentation to prove their eligibility and capacity to fulfill the tender requirements effectively.
The vaccine must be a Human Papilloma Virus Quadrivalent (Type 6, 11, 16, 18) Vaccine Recombinant PFS of 0.5 ml. It should be formulated as a recombinant product, and comprehensive documentation supporting the production processes and clinical trial data must be submitted. Adherence to quality standards is crucial for successful procurement.
The Earnest Money Deposit (EMD) amount and the conditions for submission will be specified in the tender documents. Bidders are advised to ensure that they include the EMD along with their bid submission, as failure to do so may lead to disqualification of the bid.
Documents should be submitted according to the guidelines outlined in the tender announcement, which typically requires separate submissions for the technical and financial bids. The formats for submissions must comply with the tender specifications, ensuring clarity in both electronic and physical submissions.
Yes, the tender includes provisions aimed at encouraging participation from Micro, Small, and Medium Enterprises (MSEs). Benefits may include exemptions from certain eligibility criteria or favorable evaluation conditions, fostering an environment for innovation and competition in the procurement process.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders